By Kate Holton, Andrew MacAskill and Elizabeth Piper LONDON, Jan 23 (Reuters) - British finance minister Rachel Reeves will ...

Jan 20 (Reuters) - AstraZeneca on Tuesday said it would delist its American Depositary Shares and debt securities from Nasdaq ...

AstraZeneca could build a new six-storey block at Cambridge Biomedical Campus (CBC) to house offices and a conference centre.

AstraZeneca Canada is pleased to announce that Tagrisso® (osimertinib) and Calquence® (acalabrutinib tablets) are now publicly funded in Ontario and are among the first therapies to receive ...

Daiichi Sankyo and AstraZeneca’s Enhertu has received approval from China’s NMPA for adult patients with locally advanced or ...

AstraZeneca had already bagged the rights to the AbelZeta Pharma-partnered CAR-T cell therapy for most of the world. | The ...

The acquisition gives AstraZeneca full global control of the therapy’s development, manufacturing and commercialisation.

This symposium took place during the European Society for Medical Oncology (ESMO) Congress 2025 in Berlin, Germany. The aim ...

We recently compiled a list of the Top 10 Oncology Stocks to Buy Now. AstraZeneca PLC is placed fourth on our list among the ...

AstraZeneca (NASDAQ:AZN) is one of the best future stocks to buy for the long term. On January 6, Barclays analyst James ...

AstraZeneca will buy AbelZeta Pharma’s 50% share of development and commercialization rights in China for a CAR-T therapy for ...

Delays in transferring patients with stroke for advanced treatment are linked to worse disability, fewer lifesaving procedures, and more complications, a large US study shows.